SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-18-004732
Filing Date
2018-01-29
Accepted
2018-01-29 16:30:57
Documents
1
Group Members
KOH, BONGSHAH, NIMISHVHCP CO-INVESTMENT HOLDINGS II, LLCVHCP MANAGEMENT II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G a18-3834_1sc13g.htm SC 13G 240449
  Complete submission text file 0001104659-18-004732.txt   242167
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82442 | Film No.: 18555885
SIC: 2834 Pharmaceutical Preparations

Mailing Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036 650 475 3734
Venrock Healthcare Capital Partners II, L.P. (Filed by) CIK: 0001602264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G